How to Trip Rapid Review

Step 1: Select articles relevant to your search (remember the system is only optimised for single intervention studies)

Step 2: press

Step 3: review the result, and maybe amend the or if you know better! If we're unsure of the overall sentiment of the trial we will display the conclusion under the article title. We then require you to tell us what the correct sentiment is.

9,399 results for

Cholesterol Education Resources

by
...
Latest & greatest
Alerts

Export results

Use check boxes to select individual results below

SmartSearch available

Trip's SmartSearch engine has discovered connected searches & results. Click to show

1901. Study of ARQ 092 in Patients With PIK3CA-related Overgrowth Spectrum and Proteus Syndrome

Syndrome Actual Study Start Date : May 30, 2017 Estimated Primary Completion Date : March 2020 Estimated Study Completion Date : June 2020 Resource links provided by the National Library of Medicine related topics: resources: Arms and Interventions Go to Arm Intervention/treatment Experimental: ARQ 092 All enrolled patients will receive ARQ 092 orally at 15 mg/m2 QD during the first three cycles. A study cycle is defined as 28 days. Actual dose will be calculated using body surface area (BSA), per (...) Evaluate efficacy measured as changes in performance status [ Time Frame: Day 1 of each cycle and at the end of treatment (up to 48 months) ] Changes in performance status will be measured by comparing Karnofsky/Lansky scores Eligibility Criteria Go to Information from the National Library of Medicine Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor

2017 Clinical Trials

1902. Duodenal Switch With a Standard Versus Long Alimentary Limb

(Participant, Care Provider) Primary Purpose: Treatment Official Title: Prospective Randomized Trial of Duodenal Switch With a Standard Versus Long Alimentary Limb. Study Start Date : May 2013 Actual Primary Completion Date : March 2018 Actual Study Completion Date : March 2018 Resource links provided by the National Library of Medicine related topics: Arms and Interventions Go to Arm Intervention/treatment Active Comparator: Standard BPD-DS Standard BPD-DS with a 250-cm alimentary limb and 100-cm common (...) of Hypertension [ Time Frame: 6,12,18,24 months ] Resolution rate of hypertension, base on normalized blood pressure without medication Resolution of dyslipidemia [ Time Frame: 6,12,18,24 months ] Percentage of patients with normalized cholesterol without medication Resolution of sleep apnea [ Time Frame: 6,12,18,24 months ] Percentage of patients with normalized sleep apnea testing without airway support Eligibility Criteria Go to Information from the National Library of Medicine Choosing to participate

2017 Clinical Trials

1903. Safety and Efficacy of Bexagliflozin Compared to Sitagliptin as Add-on Therapy to Metformin in Type 2 Diabetes Subjects

Start Date : October 12, 2017 Actual Primary Completion Date : July 11, 2018 Actual Study Completion Date : August 15, 2018 Resource links provided by the National Library of Medicine related topics: available for: Arms and Interventions Go to Arm Intervention/treatment Active Comparator: Bexagliflozin Subjects will receive a bexagliflozin tablet, 20 mg, once daily for the duration of the study. Subjects will continue taking metformin and receive placebo for sitagliptin daily for the duration (...) in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Layout table for eligibility information Ages Eligible for Study: 18 Years and older (Adult, Older Adult) Sexes Eligible for Study: All Accepts Healthy Volunteers: No Criteria Inclusion Criteria: Diagnosis of T2DM Currently taking

2017 Clinical Trials

1904. Safety and Tolerability of Krill Powder Supplement in Slightly Overweight People With Moderately Elevated Blood Pressure

: Nutritional counselling B Not Applicable Detailed Description: Krill powder is a food supplement rich in active ingredients such as fatty acids, phospholipids, protein and antioxidants like astaxanthin. It is considered to be more effective in lowering triglyceride values than fish oils and it may have positive effect on cholesterol values as well. Krill proteins may have positive effect on blood pressure and astaxanthin has anti-oxidative and anti-inflammatory properties. Thus, krill powder has a lot (...) -3 or other fatty acid supplements, plant sterols or fiber supplements 4 weeks before randomization Lack of suitability for participation in the trial, for any medical reason, as judged by the PI Contacts and Locations Go to Information from the National Library of Medicine To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor. Please refer to this study by its ClinicalTrials.gov identifier (NCT number

2017 Clinical Trials

1905. Phase II Trial of Ribociclib and Everolimus in Advanced Dedifferentiated Liposarcoma (DDL) and Leiomyosarcoma (LMS)

: Treatment Official Title: Phase II Trial of Ribociclib in Combination With Everolimus in Advanced Dedifferentiated Liposarcoma (DDL) and Leiomyosarcoma (LMS) Actual Study Start Date : August 8, 2017 Estimated Primary Completion Date : December 2019 Estimated Study Completion Date : December 2019 Resource links provided by the National Library of Medicine related topics: available for: resources: Arms and Interventions Go to Arm Intervention/treatment Experimental: Dedifferentiated Liposarcoma Arm (...) is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Layout table for eligibility information Ages Eligible for Study: 18 Years and older (Adult, Older Adult) Sexes Eligible for Study: All Accepts Healthy Volunteers: No Criteria Inclusion Criteria Step 1: Male or female patients 18 years or older

2017 Clinical Trials

1906. Effect of MD1003 in Amyotrophic Lateral Sclerosis

mg/day. Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor) Primary Purpose: Other Official Title: Effect of MD1003 in Amyotrophic Lateral Sclerosis: a Randomized Double Blind Placebo Controlled Pilot Study Actual Study Start Date : June 29, 2016 Actual Primary Completion Date : June 12, 2017 Estimated Study Completion Date : December 2017 Resource links provided by the National Library of Medicine related topics: related topics: available for: resources: Arms (...) , creatinine, glycaemia AST (aspartate aminotransferase ), ALT (alanine aminotransferase) , bilirubin, GGT (gamma-glutamyltransferase), alkaline phosphatase Triglyceride, cholesterol Haemostasis: APPT (activated partial thromboplastin time), PT (prothrombin time ) Secondary Outcome Measures : Motor disability [ Time Frame: 6 months ] this is evaluated using the ALSFRS-R scale (score of 48 points). Among the criteria used to evaluate the severity of ALS, the rate of the decline in the ALSFRS-R is the one

2017 Clinical Trials

1907. Effect of SLC30A8 rs13266634 Genetic Polymorphism on Zinc Supplementation and Glycemic Control in Egyptian Patients With Type 2 Diabetes Mellitus

Date : May 2017 Resource links provided by the National Library of Medicine related topics: related topics: available for: Arms and Interventions Go to Arm Intervention/treatment Active Comparator: zinc supplement plus vitamin A and E patients will be receiving zinc supplement plus vitamin A and E for 3 months. Drug: zinc supplement plus vitamin A and E Active Comparator: vitamin A and E patients will be receiving equivalent dose of vitamin A and E only for 3 months Drug: vitamin A and E (...) and three months ] change from baseline in lipid profile at three months [ Time Frame: base line and three months ] lipid profile: total cholesterol, triglyceride, HDL, LDL. change from baseline in fasting serum insulin at three months [ Time Frame: baseline and three months ] change from baseline in ALT level at three months [ Time Frame: baseline and three months ] serum Mg [ Time Frame: baseline ] creatinine level [ Time Frame: baseline ] serum Iron [ Time Frame: baseline ] change from baseline

2017 Clinical Trials

1908. Effect of GLP-1 Receptor Agonism After Sleeve Gastrectomy

: Other Official Title: Effect of GLP-1 Receptor Agonism on Weight and Caloric Intake in Subjects After Sleeve Gastrectomy Actual Study Start Date : June 22, 2017 Estimated Primary Completion Date : May 2020 Estimated Study Completion Date : December 2020 Resource links provided by the National Library of Medicine related topics: available for: Arms and Interventions Go to Arm Intervention/treatment Placebo Comparator: Sleeve Gastrectomy Placebo Subjects undergoing Sleeve Gastrectomy (SG (...) administration (3mg daily) to participants after SG Secondary Outcome Measures : Agonism of the GLP-1 receptor will lower blood pressure. [ Time Frame: 33 months ] Liraglutide administration (3mg daily) to participants after SG Agonism of the GLP-1 receptor will lower LDL-cholesterol [ Time Frame: 33 months ] Liraglutide administration (3mg daily) to participants after SG Eligibility Criteria Go to Information from the National Library of Medicine Choosing to participate in a study is an important personal

2017 Clinical Trials

1909. Reducing Sedentary Behaviour: A Novel Opportunity for Managing Comorbidity in MS?

by research evidence showing that too much sedentary time, especially prolonged bouts of sitting, is associated with health risk factors such as obesity and cholesterol level. Recent work with persons with MS confirms that prolonged sitting is a problem for this population and emphasises the potential importance of this approach. This study tests the feasibility of an internet-based intervention designed to decrease sedentary behaviour and to increase upright time in people with MS. Condition or disease (...) 28, 2019 Estimated Study Completion Date : April 30, 2019 Resource links provided by the National Library of Medicine related topics: related topics: Arms and Interventions Go to Arm Intervention/treatment Experimental: Sit Less with MS The Sit Less with MS program is based on Social Cognitive Theory (SCT) and consists of strategies that will enable people with MS to 'sit less' by frequently interrupting sitting and 'move more' by replacing sitting with light-intensity activity during waking

2017 Clinical Trials

1910. Prevalence of Adrenal Insufficiency in Kidney Transplanted Patients in Glucocorticoid Treatment

: Observational Estimated Enrollment : 60 participants Observational Model: Cohort Time Perspective: Cross-Sectional Official Title: Prevalence of Adrenal Insufficiency in Kidney Transplanted Patients (NTx) in Glucocorticoid Treatment Actual Study Start Date : March 20, 2017 Estimated Primary Completion Date : February 1, 2019 Estimated Study Completion Date : June 1, 2019 Resource links provided by the National Library of Medicine related topics: related topics: available for: resources: Groups and Cohorts (...) from the patients on the same day as the Synacthen® test. ] Results from Dxa-scan. Metabolic syndrome. [ Time Frame: The waistline and blood pressure are measured at the study visit after the Synacthen® test. The blood samples are collected as part of the test and analyazed on the same day. ] Waistline, triglyceride level, HDL cholesterol level, blood pressure and fasting blood sugar is assessed in all the patients. Salivary cortisol profiles. [ Time Frame: Saliva is sampled from each patient

2017 Clinical Trials

1911. Efficacy and Safety of Semaglutide Versus Canagliflozin as add-on to Metformin in Subjects With Type 2 Diabetes

and Safety of Semaglutide Versus Canagliflozin as add-on to Metformin in Subjects With Type 2 Diabetes Actual Study Start Date : March 15, 2017 Actual Primary Completion Date : October 16, 2018 Actual Study Completion Date : November 16, 2018 Resource links provided by the National Library of Medicine related topics: available for: Arms and Interventions Go to Arm Intervention/treatment Experimental: Semaglutide + canagliflozin placebo Drug: Semaglutide Following a dose escalation phase of 8 weeks (...) cholesterol [ Time Frame: Week 0, week 52 ] Measured in mg/dl or other equivalent SI units Change in fasting blood lipids: low density lipoprotein cholesterol (LDL) [ Time Frame: Week 0, week 52 ] Measured in mg/dl or other equivalent SI units Change in fasting blood lipids: high density lipoprotein cholesterol (HDL) [ Time Frame: Week 0, week 52 ] Measured in mg/dl or other equivalent SI units Change in fasting blood lipids: triglycerides [ Time Frame: Week 0, week 52 ] Measured in mg/dl or other

2017 Clinical Trials

1912. Complex Multiple Risk Behavior Intervention in People Between 45 to 75 Years (EIRA Study)

to make a greater number of visits. Group intervention is carried out through health education workshops. These workshops take place 15-20 days after initiating the individual intervention and they are conducted by primary care providers in the health center. A group of 12-15 people attend in each workshop. Community intervention focuses mainly on the social prescription of resources and activities that are carried out in the community where the participant person resides. In addition the intervention (...) invested in training and organizational meetings [ Time Frame: at 12 months post intervention ] Cost of time invested in training and organizational meetings to carry out the intervention. Implementation: feasibility [ Time Frame: at 12 months post intervention ] On the basis of the calculation of participation, recruitment and retention rate. Implementation: fidelity of the motivational interview technique [ Time Frame: Within 2 months prior to the start of the intervention ] The quality

2017 Clinical Trials

1913. The Impact of Vitamin D Supplementation on Glucose Metabolism in Chinese Women With Former Gestational Diabetes Mellitus

: 9 months ] change in triglyceride,cholesterol,HDL,LDL and FFA(free fatty acid) change in metabolism of calcium and phosphorus [ Time Frame: 9 months ] change in calcium, phosphorus,the ratio of urine calcium and creatinine Eligibility Criteria Go to Information from the National Library of Medicine Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your (...) Date : December 30, 2018 Estimated Study Completion Date : January 31, 2019 Resource links provided by the National Library of Medicine related topics: related topics: available for: Arms and Interventions Go to Arm Intervention/treatment Experimental: vitamin D intervention group(NGR) normal glucose regulation group according to the oral glucose tolerance test (OGTT) around 42 days postpartum. took 1600 units of vitamin D daily for nine months and meanwhile receive lifestyle intervention. Drug

2017 Clinical Trials

1914. Milk as a Recovery Beverage After Exercise for Improving Metabolic Health

) Sexes Eligible for Study: All Accepts Healthy Volunteers: Yes Criteria Inclusion Criteria: Body mass index of 25 or greater 18-44 years of age Exclusion Criteria: diabetics smokers those taking medications for cholesterol or glucose those who are allergic to milk Contacts and Locations Go to Information from the National Library of Medicine To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor. Please refer (...) Resource links provided by the National Library of Medicine related topics: Arms and Interventions Go to Arm Intervention/treatment Experimental: Exercise only 90 minutes of exercise Behavioral: Exercise 90 minutes of moderate-intensity walking exercise on a treadmill Experimental: Exercise and high glycemic index drink 90 minutes of exercise followed by consumption of high-glycemic index Gatorade drink matched for calories expended during the exercise Behavioral: Exercise 90 minutes of moderate

2017 Clinical Trials

1915. Pharmacist CVD Intervention for Patients With Inflammatory Arthritis

cholesterol, diabetes, and physical inactivity. Such factors are common and not well controlled. Inflammatory arthritis (IA) (Inflammation of the joints and other tissues) is considered another risk factor or CVD. As such, people who have IA and any of the previously mentioned risk factors would be at high risk for developing CVD. Controlling these factors will bring down the risk of having cardiovascular disease and make the quality of the individuals' life better. Pharmacists work with patients (...) and their family doctors to provide cardiovascular care. Having a pharmacist involved in the care process may help patients with IA reduce their CV risk. Pharmacists are easier to reach and may have more opportunities to educate people about medications. This might lead to better prevention and control of cardiovascular diseases. Condition or disease Intervention/treatment Phase Inflammatory Arthritis Cardiovascular Risk Factor Rheumatoid Arthritis Ankylosing Spondylitis Psoriatic Arthritis Other: CV risk

2017 Clinical Trials

1916. Sedentary Behaviour, Physical Activity and Cardiometabolic Risk in Chronic Obstructive Pulmonary Disease

device. The amount of sitting time will then be compared with cardiovascular (heart disease) risk markers, diabetes risk markers and body composition (i.e. fat and muscle mass). The measurement of cardiovascular and diabetes risk markers will include blood tests to look at blood sugar levels, lipids, cholesterol and insulin resistance as well as blood pressure and heart rate measurement. Body composition measurements will include height, weight, waist circumference, hip circumference as well (...) : October 18, 2016 Actual Primary Completion Date : August 15, 2017 Actual Study Completion Date : August 15, 2017 Resource links provided by the National Library of Medicine related topics: (AHRQ) related information: Groups and Cohorts Go to Group/Cohort Chronic Obstructive Pulmonary Disease Patients with a diagnosis of Chronic Obstructive Pulmonary Disease Healthy Volunteers Volunteers without any respiratory condition or symptoms Outcome Measures Go to Primary Outcome Measures : cardiometabolic risk

2017 Clinical Trials

1917. A Study to Investigate the Efficacy and Safety of Canagliflozin in Children and Adolescents (>=10 to <18 Years) With Type 2 Diabetes Mellitus

Purpose: Treatment Official Title: A Randomized, Multicenter, Double-Blind, Parallel-Group, Placebo-Controlled Study to Investigate the Efficacy and Safety of Canagliflozin in Children and Adolescents (≥10 to <18 Years) With Type 2 Diabetes Mellitus Actual Study Start Date : July 21, 2017 Estimated Primary Completion Date : June 28, 2021 Estimated Study Completion Date : June 15, 2022 Resource links provided by the National Library of Medicine related topics: available for: Arms and Interventions Go (...) Change in Fasting Plasma Lipid Levels From Baseline at Week 26 and Week 52 [ Time Frame: Baseline (Day 1), Week 26 and Week 52 ] The percentage change from baseline in fasting plasma lipids (low-density lipoprotein-cholesterol [LDL-C], high-density lipoprotein-cholesterol [HDL-C], total cholesterol, non-HDL-C, and triglycerides) at Week 26 and Week 52 will be assessed. Percent Change in LDL-C to HDL-C Ratio and Non-HDL-C to LDL-C Ratio From Baseline at Week 26 and Week 52 [ Time Frame: Baseline (Day

2017 Clinical Trials

1918. Dietary Prevention of Heart Failure in Hypertensive Metabolic Syndrome

Sponsor: VA Office of Research and Development Information provided by (Responsible Party): VA Office of Research and Development Study Details Study Description Go to Brief Summary: Tens of thousands of Veterans have heart failure with preserved ejection fraction (HFpEF), and suffer poor quality of life, frequent hospitalizations, and high death rates. Older Veterans and those with high blood pressure, obesity, and the metabolic syndrome (abnormal cholesterol and resistance to insulin's effects (...) as these Veterans age. Preventive efforts are critical, but are hampered by gaps in knowledge related to HFpEF pathophysiology. The long term goal of this proposal is to prevent the onset of HFpEF in at-risk Veterans. Hypertension (HTN) confers the highest population-attributable risk for HFpEF, particularly when accompanied by the metabolic syndrome, a constellation of obesity, insulin resistance, and dyslipidemia. Animal models of HTN and metabolic syndrome develop HFpEF due to microvascular oxidative stress

2017 Clinical Trials

1919. Influence of Exercise on Trans Fatty Acids

: None (Open Label) Primary Purpose: Basic Science Official Title: Influences of Physical Activity in the Profile of Trans Fatty Acids in the Serum of Individuals With Body Weight Changes Estimated Study Start Date : May 2017 Estimated Primary Completion Date : July 2017 Estimated Study Completion Date : September 2017 Resource links provided by the National Library of Medicine related topics: Arms and Interventions Go to Arm Intervention/treatment Experimental: Comparison of fatty acids before (...) Influence of Exercise on Trans Fatty Acids Influence of Exercise on Trans Fatty Acids - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100). Please remove one or more studies before adding more. Influence of Exercise on Trans Fatty Acids The safety and scientific

2017 Clinical Trials

1920. Effects of Exercise on Fructose-induced Postprandial Lipemia

Intervention Model: Crossover Assignment Masking: Double (Participant, Outcomes Assessor) Primary Purpose: Prevention Official Title: Effects of Exercise on Fructose-induced Postprandial Lipemia Actual Study Start Date : January 10, 2016 Actual Primary Completion Date : December 15, 2016 Actual Study Completion Date : December 15, 2016 Resource links provided by the National Library of Medicine related topics: available for: resources: Arms and Interventions Go to Arm Intervention/treatment Experimental (...) Measures : Triglycerides [ Time Frame: 4 hour postprandial test ] Parameter was analyzed by Cobas C111 VLDL [ Time Frame: 4 hour postprandial test ] Parameter was analyzed by ELISA Secondary Outcome Measures : Glycemia [ Time Frame: 4 hour postprandial test ] Parameter was analyzed by Cobas C111 Insulin [ Time Frame: 4 hour postprandial test ] Parameter was analyzed by Cobas C111 HDL [ Time Frame: 4 hour postprandial test ] Parameter was analyzed by Cobas C111 Non-HDL cholesterol [ Time Frame: 4 hour

2017 Clinical Trials

To help you find the content you need quickly, you can filter your results via the categories on the right-hand side >>>>